Status:
UNKNOWN
Rectal Dexmedetomidine Niosomes for Postoperative Analgesia in Pediatric Cancer Patients.
Lead Sponsor:
Assiut University
Conditions:
Postoperative Pain
Eligibility:
All Genders
3-7 years
Phase:
PHASE2
PHASE3
Brief Summary
Applying nanotechnology in drug delivery systems improved the bioavailability and kinetic profile of drugs in biological systems
Detailed Description
Nanotechnology which is focused on studying the properties and the applications of materials with structure size in the range of 1-100 nm has been widely used in various fields. In biomedical research...
Eligibility Criteria
Inclusion
- ASA physical status I and II.
- Aged 3-7 yrs.
- Undergoing bone marrow aspiration and biopsy.
Exclusion
- Allergy to the study drugs.
- Significant organ dysfunction.
- Cardiac dysrhythmia.
- Congenital heart disease.
- Use of psychotropic medication.
- Mental retardation.
Key Trial Info
Start Date :
May 1 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2023
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT05340725
Start Date
May 1 2022
End Date
December 1 2023
Last Update
January 23 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
South Egypt cancer institute, Assiut university
Asyut, Assiut Governorate, Egypt, 715715